SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corp. (AMEX:INO), focused on the development of genetic vaccines for infections and cancers and a novel replacement therapy to surgery for treatment of cancers, announced today that Bob Rieder has been elected to its board of directors. Mr. Rieder, widely known in the industry for his broad experience in managing and financing life science companies, is Chief Executive Officer and Chairman of Cardiome Pharma Corp.
